INOZYME PHARMA, INC. Operating Lease, Liability, Noncurrent
INOZYME PHARMA, INC. had Operating Lease, Liability, Noncurrent of $0 as of 2024-12-31, per its 10-K filed 2025-03-10.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2025-03-10
- 2024-12-31: Operating Lease, Liability, Noncurrent $0.00.
- 2024-09-30: Operating Lease, Liability, Noncurrent $164.00K.
- 2024-06-30: Operating Lease, Liability, Noncurrent $419.00K.
- 2024-03-31: Operating Lease, Liability, Noncurrent $669.00K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-10 |
| 2024-09-30 | $164.00K 10-Q · filed 2024-11-05 |
| 2024-06-30 | $419.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $669.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $913.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $1.15M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.38M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.60M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.82M 10-K · filed 2024-03-12 |
| 2022-09-30 | $2.04M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $2.24M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $2.44M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $2.64M 10-K · filed 2023-03-22 |
| 2021-09-30 | $2.83M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $3.01M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $3.19M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.29M 10-K · filed 2022-03-15 |